FORA Capital’s Fulgent Genetics FLGT Stock Holding History

FORA Capital’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,049	Closed	-$42K	–	990
2020 Q3	$42K	Buy	+1,049	New	+$32.8K	0.03%	466

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RJT

Raymond James Trust St. Petersburg, Florida $4.6B AUM 33.54% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

FORA Capital's FLGT Position: Q4 2020 in Review

FORA Capital sold out of Fulgent Genetics (FLGT) in Q4 2020, closing a stake of 1,049 shares — an estimated $42K sold.

FORA Capital first reported a position in FLGT in Q3 2020 and held it in 1 quarter. The position peaked at $42K in Q3 2020. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2020.

FORA Capital reported no remaining Fulgent Genetics position as of Q4 2020 after selling out during the quarter.
FORA Capital sold 1,049 Fulgent Genetics shares in Q4 2020, an estimated $42K.
FORA Capital first reported a position in Fulgent Genetics in Q3 2020 and held it in 1 quarter.
FORA Capital's Fulgent Genetics position peaked at $42K in Q3 2020.
196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2020.

Based on FORA Capital's 13F filing for Q4 2020, filed 12 Feb 2021.